Peroxynitrite increases protein phosphatase activity and promotes the interaction of phospholamban with protein phosphatase 2a in the myocardium

Nitric Oxide - Biology and Chemistry

Volumn 20, Issue 3, 2009, Pages 217-221

  Kohr, Mark J ^a   Davis, Jonathan P ^a   Ziolo, Mark T ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Co immunoprecipitation; Heart failure; Phosphorylation

Indexed keywords

LINSIDOMINE; OKADAIC ACID; PEROXYNITRITE; PHOSPHOLAMBAN; PHOSPHOPROTEIN PHOSPHATASE 1; PHOSPHOPROTEIN PHOSPHATASE 2A; SPERMINE; URATE;

ANIMAL TISSUE; ARTICLE; ENZYME ACTIVITY; HEART CONTRACTION; HEART FAILURE; HEART MUSCLE; IMMUNOPRECIPITATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

EID: 61849127277     PISSN: 10898603     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.niox.2009.01.003     Document Type: Article

References (31)

1. Mihm M.J., Coyle C.M., Schanbacher B.L., Weinstein D.M., and Bauer J.A. Peroxynitrite induced nitration and inactivation of myofibrillar creatine kinase in experimental heart failure. Cardiovasc. Res. 49 (2001) 798-807
2. Zhang P., Xu X., Hu X., van Deel E.D., Zhu G., and Chen Y. Inducible nitric oxide synthase deficiency protects the heart from systolic overload-induced ventricular hypertrophy and congestive heart failure. Circ. Res. 100 (2007) 1089-1098
3. Lopez B.L., Liu G.L., Christopher T.A., and Ma X.L. Peroxynitrite, the product of nitric oxide and superoxide, causes myocardial injury in the isolated perfused rat heart. Coron. Artery Dis. 8 (1997) 149-153
4. Ferdinandy P., Panas D., and Schulz R. Peroxynitrite contributes to spontaneous loss of cardiac efficiency in isolated working rat hearts. Am. J. Physiol. 276 (1999) H1861-H1867
5. Ferdinandy P., Danial H., Ambrus I., Rothery R.A., and Schulz R. Peroxynitrite is a major contributor to cytokine-induced myocardial contractile failure. Circ. Res. 87 (2000) 241-247
6. Stojanovic M.O., Ziolo M.T., Wahler G.M., and Wolska B.M. Anti-adrenergic effects of nitric oxide donor SIN-1 in rat cardiac myocytes. Am. J. Physiol. Cell Physiol. 281 (2001) C342-C349
7. Kohr M.J., Wang H., Wheeler D.G., Velayutham M., Zweier J.L., and Ziolo M.T. Targeting of phospholamban by peroxynitrite decreases {beta}-adrenergic stimulation in cardiomyocytes. Cardiovasc. Res. 77 (2008) 353-361
8. Chu G., Lester J.W., Young K.B., Luo W., Zhai J., and Kranias E.G. A single site (Ser16) phosphorylation in phospholamban is sufficient in mediating its maximal cardiac responses to beta-agonists. J. Biol. Chem. 275 (2000) 38938-38943
9. Bassani J.W., Yuan W., and Bers D.M. Fractional SR Ca release is regulated by trigger Ca and SR Ca content in cardiac myocytes. Am. J. Physiol. 268 (1995) C1313-C1319
10. MacDougall L.K., Jones L.R., and Cohen P. Identification of the major protein phosphatases in mammalian cardiac muscle which dephosphorylate phospholamban. Eur. J. Biochem. 196 (1991) 725-734
11. Lopez C.J., Qayyum I., Mishra O.P., and Delivoria-Papadopoulos M. Effect of nitration on protein tyrosine phosphatase and protein phosphatase activity in neuronal cell membranes of newborn piglets. Neurosci. Lett. 386 (2005) 78-81
12. + transport in human red blood cells. Cell Physiol. Biochem. 15 (2005) 271-280
13. Girouard H., Park L., Anrather J., Zhou P., and Iadecola C. Cerebrovascular nitrosative stress mediates neurovascular and endothelial dysfunction induced by angiotensin II. Arterioscler. Thromb. Vasc. Biol. 27 (2007) 303-309
14. Trackey J.L., Uliasz T.F., and Hewett S.J. SIN-1-induced cytotoxicity in mixed cortical cell culture: peroxynitrite-dependent and -independent induction of excitotoxic cell death. J. Neurochem. 79 (2001) 445-455
15. Kohr M.J., Wang H., Wheeler D.G., Velayutham M., Zweier J.L., and Ziolo M.T. Biphasic effect of SIN-1 is reliant upon cardiomyocyte contractile state. Free Radic. Biol. Med. 45 (2008) 73-80
16. Ziolo M.T., Katoh H., and Bers D.M. Positive and negative effects of nitric oxide on Ca(2+) sparks: influence of beta-adrenergic stimulation. Am. J. Physiol. Heart Circ. Physiol. 281 (2001) H2295-H2303
17. Braz J.C., Gregory K., Pathak A., Zhao W., Sahin B., Klevitsky R., Kimball T.F., Lorenz J.N., Nairn A.C., Liggett S.B., Bodi I., Wang S., Schwartz A., Lakatta E.G., DePaoli-Roach A.A., Robbins J., Hewett T.E., Bibb J.A., Westfall M.V., Kranias E.G., and Molkentin J.D. PKC-alpha regulates cardiac contractility and propensity toward heart failure. Nat. Med. 10 (2004) 248-254
18. Carr A.N., Schmidt A.G., Suzuki Y., del Monte F., Sato Y., Lanner C., Breeden K., Jing S.L., Allen P.B., Greengard P., Yatani A., Hoit B.D., Grupp I.L., Hajjar R.J., DePaoli-Roach A.A., and Kranias E.G. Type 1 phosphatase, a negative regulator of cardiac function. Mol. Cell. Biol. 22 (2002) 4124-4135
19. Gergs U., Boknik P., Buchwalow I., Fabritz L., Matus M., Justus I., Hanske G., Schmitz W., and Neumann J. Overexpression of the catalytic subunit of protein phosphatase 2A impairs cardiac function. J. Biol. Chem. 279 (2004) 40827-40834
20. Boknik P., Fockenbrock M., Herzig S., Knapp J., Linck B., Luss H., Muller F.U., Muller T., Schmitz W., Schroder F., and Neumann J. Protein phosphatase activity is increased in a rat model of long-term beta-adrenergic stimulation. Naunyn Schmiedebergs Arch. Pharmacol. 362 (2000) 222-231
21. Sommer D., Coleman S., Swanson S.A., and Stemmer P.M. Differential susceptibilities of serine/threonine phosphatases to oxidative and nitrosative stress. Arch. Biochem. Biophys. 404 (2002) 271-278
22. Herzig S., and Neumann J. Effects of serine/threonine protein phosphatases on ion channels in excitable membranes. Physiol. Rev. 80 (2000) 173-210
23. 2+ transients. Circulation 109 (2004) 1886-1891
24. Bartel S., Stein B., Eschenhagen T., Mende U., Neumann J., Schmitz W., Krause E.G., Karczewski P., and Scholz H. Protein phosphorylation in isolated trabeculae from nonfailing and failing human hearts. Mol. Cell. Biochem. 157 (1996) 171-179
25. Sande J.B., Sjaastad I., Hoen I.B., Bokenes J., Tonnessen T., Holt E., Lunde P.K., and Christensen G. Reduced level of serine(16) phosphorylated phospholamban in the failing rat myocardium: a major contributor to reduced SERCA2 activity. Cardiovasc. Res. 53 (2002) 382-391
26. Schwinger R.H., Munch G., Bolck B., Karczewski P., Krause E.G., and Erdmann E. Reduced Ca(2+)-sensitivity of SERCA 2a in failing human myocardium due to reduced serin-16 phospholamban phosphorylation. J. Mol. Cell Cardiol. 31 (1999) 479-491
27. Neumann J., Boknik P., Herzig S., Schmitz W., Scholz H., Gupta R.C., and Watanabe A.M. Evidence for physiological functions of protein phosphatases in the heart: evaluation with okadaic acid. Am. J. Physiol. 265 (1993) H257-H266
28. Terentyev D., Viatchenko-Karpinski S., Gyorke I., Terentyeva R., and Gyorke S. Protein phosphatases decrease sarcoplasmic reticulum calcium content by stimulating calcium release in cardiac myocytes. J. Physiol. 552 (2003) 109-118
29. Ziolo M.T., Katoh H., and Bers D.M. Expression of inducible nitric oxide synthase depresses beta-adrenergic-stimulated calcium release from the sarcoplasmic reticulum in intact ventricular myocytes. Circulation 104 (2001) 2961-2966
30. Knyushko T.V., Sharov V.S., Williams T.D., Schoneich C., and Bigelow D.J. 3-Nitrotyrosine modification of SERCA2a in the aging heart: a distinct signature of the cellular redox environment. Biochemistry 44 (2005) 13071-13081
31. 2+-ATPase in human heart failure. Circulation 111 (2005) 988-995